The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidental discovery of second primary malignancies in patients diagnosed with breast cancer: An institutional case series.
 
Alexandra Iancu
No Relationships to Disclose
 
Poorni Manohar
No Relationships to Disclose
 
Shaveta Vinayak
Consulting or Advisory Role - OncoSec
Research Funding - OncoSec (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst)
 
William R. Gwin
Consulting or Advisory Role - CoreA Therapeutics
Research Funding - Lilly; Veana Therapeutics
 
Hannah M. Linden
Leadership - Evolent (I); Progyny (I)
Stock and Other Ownership Interests - Evolent (I)
Consulting or Advisory Role - GE Healthcare; Novartis; Pfizer; Sanofi
Research Funding - Pfizer (Inst); Sanofi/Aventis (Inst); Tolmar (Inst); Zeno Pharmaceuticals (Inst); Zionexa (Inst); Zymeworks (Inst)
 
Jennifer M. Specht
Honoraria - Daiichi Sankyo; GE Healthcare; GlaxoSmithKline; Sensei Biotherapeutics
Consulting or Advisory Role - Daiichi Sankyo; GE Healthcare; GlaxoSmithKline; Sensei Biotherapeutics
Research Funding - Abbvie (Inst); Cascadian Therapeutics (Inst); Celcuity (Inst); Genentech (Inst); Merck (Inst); Minerva Biotechnologies (Inst); Myriad Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - GE Healthcare; GlaxoSmithKline; Nektar
 
Lynn Katherine Symonds
No Relationships to Disclose
 
Nancy E. Davidson
No Relationships to Disclose
 
Natasha Hunter
No Relationships to Disclose